Nav: Home

Immortalized blood cell lines enable new studies of malaria invasion

August 29, 2019

Researchers[1] at the University of Bristol and Imperial College London have established a new model system that uses red blood cells grown in the laboratory to study how malaria parasites invade red blood cells.

The work, which was funded by the National Institute for Health Research and NHS Blood and Transplant and is published in Nature Communications, provides a powerful new research tool for the identification of key host proteins and their domains that are involved in parasite infection. It will facilitate attempts to understand and disrupt the mechanism of red blood cell invasion by malaria parasites.

The scientists used a cell line recently developed in Bristol which can produce unlimited numbers of immature 'progenitor cells' that can be pushed to produce new red blood cells (reticulocytes) in the laboratory. Using these cells, they were able to show that red blood cells generated using this technique can support both invasion by and intracellular development of Plasmodium falciparum, the malaria parasite that is responsible for around 200 million new infections and half a million deaths per year worldwide.

By using CRISPR-Cas9 to edit the genome of the immature cells, the team were also able to remove a protein called basigin that is important for invasion and normally present on the surface of red blood cells and show that the reticulocytes generated from this edited line were completely resistant to invasion. Reintroducing the basigin gene into the edited cells restored invasion to normal levels. This important work shows that these cells can be used to remove and replace different red blood cell proteins and assess how their absence or alteration affects the ability of the parasite to successfully invade.

Dr Tim Satchwell, lead author of the study at the University of Bristol said:

"The ability to alter protein expression in the red blood cell and study the effect that these changes have on parasite invasion or development is hugely exciting. This system has opened up many new potential avenues of research that should allow us to better understand the mechanism by which the malaria parasite is able to successfully invade the red blood cell, and the specific roles that host cell proteins play in this process."

Dr Ashley Toye - one of the senior authors on the study and Director of the NIHR Blood and Transplant Research Unit said:

"This work has shown that it is now possible to manipulate the red blood cell surface to better understand the process of malaria invasion. It also shows that our reticulocytes produced from the cell line are recognised by the parasite just the same as reticulocytes produced in the body. This is important as it provides further evidence that the cells are manufactured correctly in the laboratory."

Dr Nick Watkins, Assistant Director - Research and Development at NHS Blood and Transplant, said:

"This demonstration of reticulocytes derived from cell lines supporting malaria invasion will provide an important new tool to better understand how the malaria parasite invades red blood cells. Ultimately, we hope that this work will lead to the development of new therapeutic strategies for malaria."
Genetic manipulation of cell line derived reticulocytes enables dissection of host malaria invasion requirements - Satchwell TJ, Wright KE, Haydn-Smith KL, Terán FS-R, Moura PL, Hawksworth J, Frayne J, Toye AM, Baum J

University of Bristol

Related Malaria Articles:

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Seeking better detection for chronic malaria
In people with chronic malaria, certain metabolic systems in the blood change to support a long-term host-parasite relationship, a finding that is key to eventually developing better detection, treatment and eradication of the disease, according to research published today in the Journal of Clinical Investigation Insight.
More Malaria News and Malaria Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...